The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SOPHIA: A phase 3, randomized study of margetuximab (M) plus chemotherapy (CTX) vs trastuzumab (T) plus CTX in the treatment of patients with HER2+ metastatic breast cancer (MBC).
 
Hope S. Rugo
Honoraria - Genomic Health
Speakers' Bureau - Genomic Health
Research Funding - Celsion (Inst); Celsion (Inst); Eisai (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Mylan; Nektar; Novartis; OBI Pharma; Roche/Genentech
 
Mark D. Pegram
Employment - Dava Oncology (I)
Consulting or Advisory Role - Genenetech, Pfizer, Novartis, AstraZeneca
Expert Testimony - Novartis
Travel, Accommodations, Expenses - Genentech, Pfizer, Novartis
Other Relationship - Genentech, Pfizer, Novartis, AstraZeneca
 
William John Gradishar
No Relationships to Disclose
 
Javier Cortes
Employment - MedSIR
Stock and Other Ownership Interests - MedSIR
Honoraria - Celgene; Eisai; Novartis; Roche/Genentech
Consulting or Advisory Role - Celgene; Roche/Genentech
 
Giuseppe Curigliano
No Relationships to Disclose
 
Jon M. Wigginton
Employment - Macrogenics
Leadership - Macrogenics
Stock and Other Ownership Interests - Macrogenics
 
Robert Joseph Lechleider
Employment - Macrogenics
Stock and Other Ownership Interests - MacroGenics
Consulting or Advisory Role - Geron
 
Fatima Cardoso
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Celgene; Daiichi Sankyo; Eisai; GE Healthcare; Genentech; GlaxoSmithKline; Merck Sharp & Dohme; Merus; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi; Teva
Travel, Accommodations, Expenses - Pfizer; Roche